Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Assets Average (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Assets Average for 16 consecutive years, with $3.6 billion as the latest value for Q4 2025.

  • Quarterly Assets Average fell 10.55% to $3.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 billion through Dec 2025, down 10.55% year-over-year, with the annual reading at $3.8 billion for FY2025, 2.3% down from the prior year.
  • Assets Average hit $3.6 billion in Q4 2025 for Integra Lifesciences Holdings, down from $3.7 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $4.1 billion in Q2 2024 to a low of $3.6 billion in Q4 2025.
  • Historically, Assets Average has averaged $3.8 billion across 5 years, with a median of $3.8 billion in 2021.
  • Biggest five-year swings in Assets Average: rose 9.38% in 2021 and later decreased 10.55% in 2025.
  • Year by year, Assets Average stood at $3.8 billion in 2021, then rose by 1.85% to $3.8 billion in 2022, then fell by 2.28% to $3.8 billion in 2023, then rose by 7.74% to $4.1 billion in 2024, then dropped by 10.55% to $3.6 billion in 2025.
  • Business Quant data shows Assets Average for IART at $3.6 billion in Q4 2025, $3.7 billion in Q3 2025, and $3.9 billion in Q2 2025.